Publications by authors named "Anna Aventin"

Claim this Profile
F
Feasibility of the AML profiler (Skyline™ Array) for patient risk stratification in a multicentre trial: a preliminary comparison with the conventional approach.
Josep F Nomdedéu, Eulalia Puigdecanet, Elena Bussaglia, Juan José Hernández, Maite Carricondo, Anna Aventin

Hematol Oncol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A high proportion of cells carrying trisomy 12 is associated with a worse outcome in patients with chronic lymphocytic leukemia.
Isabel González-Gascón Y Marín, María Hernández-Sánchez, Ana-Eugenia Rodríguez-Vicente, Carmen Sanzo, Anna Aventín

Hematol Oncol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complex measurements may be required to establish the prognostic impact of immunophenotypic markers in AML.
Maria Concepcion García-Dabrio, Montserrat Hoyos, Salut Brunet, Mar Tormo, Josep-Maria Ribera, Anna Aventin

Am J Clin Pathol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multilineage dysplasia is associated with a poorer prognosis in patients with de novo acute myeloid leukemia with intermediate-risk cytogenetics and wild-type NPM1.
María Rozman, José-Tomás Navarro, Leonor Arenillas, Anna Aventín, Teresa Giménez

Ann Hematol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biallelic losses of 13q do not confer a poorer outcome in chronic lymphocytic leukaemia: analysis of 627 patients with isolated 13q deletion.
Anna Puiggros, Julio Delgado, Ana Rodriguez-Vicente, Rosa Collado, Anna Aventín

Br J Haematol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Core binding factor acute myeloid leukemia: the impact of age, leukocyte count, molecular findings, and minimal residual disease.
Montserrat Hoyos, Josep F Nomdedeu, Jordi Esteve, Rafael Duarte, Josep M Ribera

Eur J Haematol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural alterations in chronic lymphocytic leukaemia. Cytogenetic and FISH analysis.
Ana Travella, Lorena Ripollés, Anna Aventin, Andrea Rodríguez, Raimundo F Bezares

Hematol Oncol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
Angela Ferrari, Elena Bussaglia, Josep Úbeda, Luca Facchini, Anna Aventin

Hematol Oncol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic lymphocytic leukaemia with 17p deletion: a retrospective analysis of prognostic factors and therapy results.
Julio Delgado, Blanca Espinet, Ana C Oliveira, Pau Abrisqueta, Javier de la Serna, Anna Aventin

Br J Haematol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NPM1 deletion is associated with gross chromosomal rearrangements in leukemia.
Roberta La Starza, Caterina Matteucci, Paolo Gorello, Lucia Brandimarte, Valentina Pierini, Anna Aventin

PLoS One· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of tetradecanoylphorbol acetate-stimulated peripheral blood cells enhances the prognostic value of interphase fluorescence in situ hybridization in patients with chronic lymphocytic leukemia.
Julio Delgado, Anna Aventin, Javier Briones, Jana Sanchez, Josep Nomdedeu

Genes Chromosomes Cancer· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.
José Cervera, Pau Montesinos, Jesús M Hernández-Rivas, María J Calasanz, Anna Aventín

Haematologica· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WT1 monitoring in core binding factor AML: comparison with specific chimeric products.
Adriana Lasa, Maite Carricondo, Camino Estivill, Elena Bussaglia, Ignasi Gich, Anna Aventin

Leuk Res· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beta2-microglobulin is a better predictor of treatment-free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rate.
Julio Delgado, Guy Pratt, Neil Phillips, Javier Briones, Chris Fegan, Anna Aventin

Br J Haematol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
K313dup is a recurrent CEBPA mutation in de novo acute myeloid leukemia (AML).
Maria J Carnicer, Adriana Lasa, Marcus Buschbeck, Elena Serrano, Maite Carricondo, Anna Aventin

Ann Hematol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel IGHalpha translocations, t(2;14)(q14.3;q32) and t(14;17)(q32;q21), in B-cell precursor acute lymphoblastic leukemia.
Anna Aventín, Jana Sánchez, Josep F Nomdedéu, Cristina Estany, Pilar Forcada

Cancer Genet Cytogenet· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.
Elena Serrano, Maria J Carnicer, Adriana Lasa, Vanesa Orantes, Jorge Pena

Leuk Res· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uniparental disomy may be associated with microsatellite instability in acute myeloid leukemia (AML) with a normal karyotype.
Elena Serrano, Maria J Carnicer, Vanesa Orantes, Camino Estivill, Adriana Lasa

Leuk Lymphoma· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High expression of CEACAM6 and CEACAM8 mRNA in acute lymphoblastic leukemias.
Adriana Lasa, Elena Serrano, Maite Carricondo, Maria J Carnicer, Salut Brunet

Ann Hematol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microsatellite instability may involve the pentanucleotide repeat of the PIG3 promoter in bcr/abl acute lymphoblastic leukemia.
Josep F Nomdedéu, Granada Perea, Camino Estivill, Isabel Badell, Adriana Lasa

Leuk Res· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of chromosomal abnormalities in chronic lymphocytic leukemia increased by interphase fluorescence in situ hybridization in tetradecanoylphorbol acetate-stimulated peripheral blood cells.
Jana Sánchez, Anna Aventín

Cancer Genet Cytogenet· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myeloid leukemia subgroups identified by pathway-restricted gene expression signatures.
Elena Serrano, Adriana Lasa, Granada Perea, Maria J Carnicer, Salut Brunet

Acta Haematol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual-color split signal fluorescence in situ hybridization assays for the detection of CALM/AF10 in t(10;11)(p13;q14-q21)-positive acute leukemia.
Roberta La Starza, Barbara Crescenzi, Alexandre Krause, Valentina Pierini, Giorgina Specchia, Anna Aventin

Haematologica· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new D816 c-KIT gene mutation in refractory AML1-ETO leukemia.
Adriana Lasa, Maria T Carricondo, Maria J Carnicer, Granada Perea, Anna Aventín

Haematologica· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Occurrence of the JAK2 V617F mutation in the WHO provisional entity: myelodysplastic/myeloproliferative disease, unclassifiable-refractory anemia with ringed sideroblasts associated with marked thrombocytosis.
Angel F Remacha, Josep F Nomdedéu, Guiomar Puget, Camino Estivill, M Pilar Sarda, Anna Aventin

Haematologica· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis